Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery

被引:15
|
作者
Geng, Tianjiao [1 ]
Leung, Euphemia [2 ]
Chamley, Lawrence W. [3 ,4 ]
Wu, Zimei [1 ]
机构
[1] Univ Auckland, Fac Med & Hlth Sci, Sch Pharm, Auckland, New Zealand
[2] Univ Auckland, Fac Med & Hlth Sci, Auckland Canc Soc, Res Ctr, Auckland, New Zealand
[3] Univ Auckland, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Auckland, New Zealand
[4] Univ Auckland, Fac Med & Hlth Sci, Hub Extracellular Vesicles Invest, Auckland, New Zealand
来源
BIOMATERIALS ADVANCES | 2023年 / 149卷
关键词
Small extracellular vesicles; Tropism; Surface modification; Integrin receptor; Cell-targeting; Intracellular trafficking; Glioblastoma; LIPOSOMES; PEPTIDE; EXOSOMES; CELLS; DOXORUBICIN; THERAPY;
D O I
10.1016/j.bioadv.2023.213388
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
With the intrinsic ability to cross the blood-brain barrier, small extracellular vesicles (sEVs) hold promise as endogenous brain-targeted drug delivery nano-platforms for glioblastoma (GBM) treatment. To increase GBM targetability, this study aimed to functionalise sEVs with cyclic arginine-glycine-aspartic acid-tyrosine-cysteine (cRGDyC), a ligand for integrin (& alpha;v & beta;3) that is overexpressed in GBM cells. Firstly, the intrinsic cellular uptake of sEVs derived from GBM U87 and pancreatic cancer MIA PaCa-2 cells was investigated on the donor cells. To obtain functionalised sEVs (cRGDyC-sEVs), DSPE-mPEG2000-maleimide was incubated with the selected (U87) sEVs, and cRGDyC was subsequently conjugated to the maleimide groups via a thiol-maleimide coupling reaction. The GBM cell targetability and intracellular trafficking of cRGDyC-sEVs were evaluated on U87 cells by fluorescence and confocal microscopy, using unmodified sEVs as a reference. The cytotoxicity of doxorubicinloaded vesicles (Dox@sEVs, Dox@cRGDyC-sEVs) was compared with a standard liposome formulation (Dox@Liposomes) and free Dox. Both U87 and MIA PaCa-2 cell-derived sEVs displayed tropism with the former being >4.9-fold more efficient to be internalised into U87. Therefore, the U87-derived sEVs were chosen for GBMtargeting. Approximately 4000 DSPE-mPEG2000-maleimide were inserted onto each sEV with cRGDyC conjugated to the maleimide group. The cell targetability of cRGDyC-sEVs to U87 cells improved 2.4-fold than natural sEVs. Despite their proneness to be colocalised with endosomes/lysosomes, both Dox@sEVs and Dox@cRGDyCsEVs showed superior cytotoxicity to U87 GBM cells compared to Dox@Liposomes, particularly Dox@cRGDyCsEVs. Overall, U87-derived sEVs were successufully conjugated with cRGDyC via a PEG linker, and cRGDyC-sEVs were demonstrated to be a potnetial integrin-targeting drug delivery vehicle for GBM treatment. Graphic abstract.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Extracellular vesicles for targeted drug delivery: triumphs and challenges
    Gudbergsson, Johann Mar
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (14) : 1285 - 1287
  • [2] Molecular Docking and Intracellular Translocation of Extracellular Vesicles for Efficient Drug Delivery
    Matsuzaka, Yasunari
    Yashiro, Ryu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [3] Conferring receptors on recipient cells with extracellular vesicles for targeted drug delivery
    Quinn, Zachary
    Mao, Wenjun
    Xia, Yiqiu
    John, Rhea
    Wan, Yuan
    BIOACTIVE MATERIALS, 2021, 6 (03) : 749 - 756
  • [4] Targeted Drug Delivery in Lipid-like Nanocages and Extracellular Vesicles
    Sokolov, A. V.
    Kostin, N. N.
    Ovchinnikova, L. A.
    Lomakin, Y. A.
    Kudriaeva, A. A.
    ACTA NATURAE, 2019, 11 (02): : 28 - 41
  • [5] Targeted Drug Delivery to the Central Nervous System Using Extracellular Vesicles
    Zhou, Lina
    Kodidela, Sunitha
    Godse, Sandip
    Thomas-Gooch, Stacey
    Kumar, Asit
    Raji, Babatunde
    Zhi, Kaining
    Kochat, Harry
    Kumar, Santosh
    PHARMACEUTICALS, 2022, 15 (03)
  • [6] Radiolabelled Extracellular Vesicles as Imaging Modalities for Precise Targeted Drug Delivery
    Ashique, Sumel
    Anand, Krishnan
    PHARMACEUTICS, 2023, 15 (05)
  • [7] Nature's carriers: leveraging extracellular vesicles for targeted drug delivery
    Chen, Qi
    Zheng, Yuyi
    Jiang, Xuhong
    Wang, Yi
    Chen, Zhong
    Wu, Di
    DRUG DELIVERY, 2024, 31 (01)
  • [8] Extracellular vesicles for drug delivery
    Vader, Pieter
    Mol, Emma A.
    Pasterkamp, Gerard
    Schiffelers, Raymond M.
    ADVANCED DRUG DELIVERY REVIEWS, 2016, 106 : 148 - 156
  • [9] Extracellular Vesicles as Novel Drug-Delivery Systems through Intracellular Communications
    Matsuzaka, Yasunari
    Yashiro, Ryu
    MEMBRANES, 2022, 12 (06)
  • [10] Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy study
    Kang, Weirong
    Svirskis, Darren
    Sarojini, Vijayalekshmi
    McGregor, Ailsa L.
    Bevitt, Joseph
    Wu, Zimei
    ONCOTARGET, 2017, 8 (22) : 36614 - 36627